In poorly and moderately differentiated ovarian cancer, the proportions of HHLA2-positive patients were 7.69 and 16%, respectively; in well-differentiated patients, the proportion of HHLA2 positive patients was 38.46% (Fig. 2k). Here, HHLA2 is linked to ovarian cancer.